D. China Babu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
D. China Babu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
C. Madhusudhana Chetty
Santhiram College of Pharmacy, Nandyal, Kurnool District, A.P. India
2 shared publicationsMadhusudhana Chetty C
2 shared publications- Aleesha Shaik
Department of Pharmacology, Sun Institute of Pharmaceutical Education and Research, Nellore, Andhra Pradesh, India
1 shared publication Angala Parameswari
Department of Pharmacy, Jagan’s Institute of Pharmaceutical Sciences, Nellore, Andhra Pradesh, India
1 shared publication- G. Sai Sri Harsha
Department of School of Pharmacy, ITM University, NH-44, Gwalior-474001, Madhya Pradesh, India
1 shared publication - G. Venkateshwarlu
Department of School of Pharmacy, ITM University, NH-44, Gwalior-474001, Madhya Pradesh, India
1 shared publication
Latest Publications
- Open Access
- 27 December 2023
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 39 (6) , 1643-1648
LC/MS/MS Method Development and Validation for the Estimation of Lasmiditan in Bulk and Pharmaceutical Formulation
Oriental Journal of Chemistry is a peer reviewed quarterly research journal of pure and applied chemistry. It publishes standard research papers in almost all thrust areas of current chemistry of academic and commercial importance. It provides a platform for rapid publication of quality research papers, reviews and chemistry letters. Oriental Journal of Chemistry is abstracted and indexed in almost all reputed National and International agencies.
- 27 December 2023
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 39 (6) , 1643-1648
Open AccessLC/MS/MS Method Development and Validation for the Estimation of Lasmiditan in Bulk and Pharmaceutical Formulation
Oriental Journal of Chemistry is a peer reviewed quarterly research journal of pure and applied chemistry. It publishes standard research papers in almost all thrust areas of current chemistry of academic and commercial importance. It provides a platform for rapid publication of quality research papers, reviews and chemistry letters. Oriental Journal of Chemistry is abstracted and indexed in almost all reputed National and International agencies.
- 4 December 2021
- Published by Indian Drug Manufacturers' Association (IDMA) in INDIAN DRUGS
- Vol. 58 (09) , 73-75
FORCED INDICATING UPLC-DAD METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF APALUTAMIDE IN BULK AND IN PHARMACEUTICAL DOSAGE FORM
A new analytical method was developed for the estimation of apalutamide in bulk and its pharmaceutical formulation. The sensitive, précise and accurate method was developed by using Waters Acquity UPLC system equipped with quaternary gradient pump. The column used was Waters C18 150 X 2.1 mm X 1.7 µm and mobile phase was 0.2 % OPA buffer in water : acetonitrile in the ratio of 25:75 V/V. The buffer pH was maintained at 4.5. The fl ow rate of mobile phase was 0.5 mL min-1 and detection was at 272 nm by using PDA detector. The method was performed at ambient temperature. The retention time of the apalutamide was 1.27 min. The % RSD value in precision was >2 %. The accuracy of the method was found to be between 99.54 % - 100.01 %. The limit of detection and limit of quantifi cation values were found to be 0.14 µg mL-1 and 0.48 µg mL-1, respectively. The linearity concentration range was found to be 11.25 - 67.5 µg mL-1, it show wide linearity concentration range. The method was proved to have good robustness after changing parameters of fl ow rate, temperature and mobile phase composition. The method showed good ability towards different stress conditions of acidity, alkalinity, peroxide and UV-light. The method can be used for the routine analysis of apalutamide in bulk and its pharmaceutical dosage form by using UPLC.
- 4 December 2021
- Published by Indian Drug Manufacturers' Association (IDMA) in INDIAN DRUGS
- Vol. 58 (09) , 73-75
FORCED INDICATING UPLC-DAD METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF APALUTAMIDE IN BULK AND IN PHARMACEUTICAL DOSAGE FORM
A new analytical method was developed for the estimation of apalutamide in bulk and its pharmaceutical formulation. The sensitive, précise and accurate method was developed by using Waters Acquity UPLC system equipped with quaternary gradient pump. The column used was Waters C18 150 X 2.1 mm X 1.7 µm and mobile phase was 0.2 % OPA buffer in water : acetonitrile in the ratio of 25:75 V/V. The buffer pH was maintained at 4.5. The fl ow rate of mobile phase was 0.5 mL min-1 and detection was at 272 nm by using PDA detector. The method was performed at ambient temperature. The retention time of the apalutamide was 1.27 min. The % RSD value in precision was >2 %. The accuracy of the method was found to be between 99.54 % - 100.01 %. The limit of detection and limit of quantifi cation values were found to be 0.14 µg mL-1 and 0.48 µg mL-1, respectively. The linearity concentration range was found to be 11.25 - 67.5 µg mL-1, it show wide linearity concentration range. The method was proved to have good robustness after changing parameters of fl ow rate, temperature and mobile phase composition. The method showed good ability towards different stress conditions of acidity, alkalinity, peroxide and UV-light. The method can be used for the routine analysis of apalutamide in bulk and its pharmaceutical dosage form by using UPLC.
- Open Access
- 7 October 2020
- Published by GP Innovations Pvt. Ltd. in International Journal of Research in Pharmaceutical Sciences
- Vol. 11 (4) , 7740-7746
Quantitative Stability Indicating Bio-analytical Method Development and Validation of Apalutamide - Apalutamide D3 By Using Ultra Performance Liquid Chromatography in Human Plasma
A simple, convenient, specific, precise and highly conventional stability-indicating ultra-performance liquid chromatographic‑ diode array method was developed for the quantification of Apalutamide in human plasma. The Phenomenex Luna (100x4.6x5µ) column was used for apalutamide separation. The mobile phase was composed with 5 mM ammonium fumarate and acetonitrile in the ratio of 15:85 v/v, and buffer pH 3.5 was adjusted with glacial acetic acid and detected at 345 nm. The Apalutamide‑D3 used as internal standard and K2‑EDTA used as a coagulant. The liquid-liquid extraction process used for extraction of drug from human plasma with tert butyl methyl ether. The retention times of Apalutamide and Apalutamide D3 (ISTD) was 1.48 min & 1.97 min, respectively. The assay of the method was validated in human plasma in the concentration range from 307.26-200013.87 pg/ml with the accuracy and precision ranging from 3.86 to 4.87. Recovery studies were found to be 103.79%, 90.93% & 96.83% for HQC, MQC and LQC respectively. The stability of the drug was evaluated in human plasma with different conditions of the auto-sampler, freeze-thaw, bench top, short term and long term stability studies were performed. The method was proved as highly sensitive and selective for the quantification of Apalutamide and determined at the picogram level. There was no matrix effect observed and proved as a stability-indicating method.
- 7 October 2020
- Published by GP Innovations Pvt. Ltd. in International Journal of Research in Pharmaceutical Sciences
- Vol. 11 (4) , 7740-7746
Open AccessQuantitative Stability Indicating Bio-analytical Method Development and Validation of Apalutamide - Apalutamide D3 By Using Ultra Performance Liquid Chromatography in Human Plasma
A simple, convenient, specific, precise and highly conventional stability-indicating ultra-performance liquid chromatographic‑ diode array method was developed for the quantification of Apalutamide in human plasma. The Phenomenex Luna (100x4.6x5µ) column was used for apalutamide separation. The mobile phase was composed with 5 mM ammonium fumarate and acetonitrile in the ratio of 15:85 v/v, and buffer pH 3.5 was adjusted with glacial acetic acid and detected at 345 nm. The Apalutamide‑D3 used as internal standard and K2‑EDTA used as a coagulant. The liquid-liquid extraction process used for extraction of drug from human plasma with tert butyl methyl ether. The retention times of Apalutamide and Apalutamide D3 (ISTD) was 1.48 min & 1.97 min, respectively. The assay of the method was validated in human plasma in the concentration range from 307.26-200013.87 pg/ml with the accuracy and precision ranging from 3.86 to 4.87. Recovery studies were found to be 103.79%, 90.93% & 96.83% for HQC, MQC and LQC respectively. The stability of the drug was evaluated in human plasma with different conditions of the auto-sampler, freeze-thaw, bench top, short term and long term stability studies were performed. The method was proved as highly sensitive and selective for the quantification of Apalutamide and determined at the picogram level. There was no matrix effect observed and proved as a stability-indicating method.
- Open Access
- 3 October 2018
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 34 (5) , 2554-2561
Novel Stress Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and its Formulation
A selective, sensitive RP-HPLC method was developed for the simultaneous estimation of the Ertugliflozin (ETR) and Sitagliptin (SGT) in bulk and its dosage form. The separation and determination was carried on water’s C18 column capacitate (250X4.6 mm, 5 µm particle size), retention times of Ertugliflozin and Sitagliptin were found to be 2.39 and 4.60 min respectively. The wavelength was fixed at 215nm with PDA detection. The mobile phase was consisted mixture of 0.5 mM potassium dihydrogen ortho phosphate buffer: Methanol in the ratio of 55:45 v/v, pH 5.3 was adjusted with HCl and flow of mobile phase was maintained 1mL/min. The calibration curve was linear and regression co-efficient (R2) value found to be 0.999 and concentration ranging from 37.5-112.5 and 250-750 µg/mL for Ertugliflozin & Sitagliptin respectively. The quantization limit and detection limit of the method were found 0.1 & 0.3 µg/ml and 0.4&1µg/ml for Ertugliflozin & Sitagliptin.
- 3 October 2018
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 34 (5) , 2554-2561
Open AccessNovel Stress Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and its Formulation
A selective, sensitive RP-HPLC method was developed for the simultaneous estimation of the Ertugliflozin (ETR) and Sitagliptin (SGT) in bulk and its dosage form. The separation and determination was carried on water’s C18 column capacitate (250X4.6 mm, 5 µm particle size), retention times of Ertugliflozin and Sitagliptin were found to be 2.39 and 4.60 min respectively. The wavelength was fixed at 215nm with PDA detection. The mobile phase was consisted mixture of 0.5 mM potassium dihydrogen ortho phosphate buffer: Methanol in the ratio of 55:45 v/v, pH 5.3 was adjusted with HCl and flow of mobile phase was maintained 1mL/min. The calibration curve was linear and regression co-efficient (R2) value found to be 0.999 and concentration ranging from 37.5-112.5 and 250-750 µg/mL for Ertugliflozin & Sitagliptin respectively. The quantization limit and detection limit of the method were found 0.1 & 0.3 µg/ml and 0.4&1µg/ml for Ertugliflozin & Sitagliptin.
- Open Access
- 10 January 2017
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 18 (5) , 1-9
Stability Indicating RP-HPLC Method Development and Validation for the Estimation of Atezolizumab in Bulk and Its Injectable Dosage Form
Aim: A new simple reversed phase high performance liquid chromatographic method was developed for the estimation of Atezolizumab in bulk and its injectable formulation. Study Design: Quantitative and qualitative estimation and degradation studies of AZM by using Rp-HPLC. Place and Duration of Study: The work was performed at Santhiram College of Pharmacy and duration of study within 3 months. Methodology: The method was developed and validated and better results were obtained by using Polaris C18-A (150 mm—4.6 mm i.d., 5µm particle size column by using mobile phase 0.1% TFA in acetonitrile: water 90:10 v/v. The mobile phase flow rate was fixed 0.75 mL/min. Results: The mean retention time was 2.2 min. Correlation coefficient calibration curve within the detection range 75-225 µg/mL and R2 value was found to be 0.999. The Detection limit and Quantification limit were performed for AZM and found to be 15.24-50.80 µg/mL. The assay was perfomed and the percentage purity of the AZM was found to be 100.27%. Forced degradation studies were performed with acid, base, water, H2O2 and UV-light. Conclusion: The preliminary results indicated that the developed method was found to be a simple specific, precise, accurate and robust for the resolve of AZM in the bulk and marketed injectable formulations.
- 10 January 2017
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 18 (5) , 1-9
Open AccessStability Indicating RP-HPLC Method Development and Validation for the Estimation of Atezolizumab in Bulk and Its Injectable Dosage Form
Aim: A new simple reversed phase high performance liquid chromatographic method was developed for the estimation of Atezolizumab in bulk and its injectable formulation. Study Design: Quantitative and qualitative estimation and degradation studies of AZM by using Rp-HPLC. Place and Duration of Study: The work was performed at Santhiram College of Pharmacy and duration of study within 3 months. Methodology: The method was developed and validated and better results were obtained by using Polaris C18-A (150 mm—4.6 mm i.d., 5µm particle size column by using mobile phase 0.1% TFA in acetonitrile: water 90:10 v/v. The mobile phase flow rate was fixed 0.75 mL/min. Results: The mean retention time was 2.2 min. Correlation coefficient calibration curve within the detection range 75-225 µg/mL and R2 value was found to be 0.999. The Detection limit and Quantification limit were performed for AZM and found to be 15.24-50.80 µg/mL. The assay was perfomed and the percentage purity of the AZM was found to be 100.27%. Forced degradation studies were performed with acid, base, water, H2O2 and UV-light. Conclusion: The preliminary results indicated that the developed method was found to be a simple specific, precise, accurate and robust for the resolve of AZM in the bulk and marketed injectable formulations.